Today: 25 January 2026
Subscribe
Browse Category

NASDAQ:AMGN News 10 January 2026 - 24 January 2026

Amgen stock pulled back after a six-day run — here’s what investors watch next week

Amgen stock pulled back after a six-day run — here’s what investors watch next week

New York, Jan 24, 2026, 17:24 EST — Market closed. Amgen Inc. shares dipped 0.7% on Friday, closing at $344.75. This halted a six-day winning streak, though the stock still stands roughly 4% higher than it was a week ago. (StockAnalysis) The stock hit $349.98 on Thursday, pressing against the upper boundary of its 52-week range, which spans from $261.43…
24 January 2026
····
Amgen stock on watch as JPMorgan conference speech looms after two-day slide

Amgen stock on watch as JPMorgan conference speech looms after two-day slide

New York, Jan 11, 2026, 16:51 EST — Market closed. Amgen (AMGN.O) shares head into Monday’s session with investors looking to Chief Executive Robert Bradway’s J.P. Morgan Healthcare Conference remarks for the next clear catalyst. (Amgen) The annual healthcare conference is one of the first big trade-and-talk events of the year for drugmakers. Traders will be listening for what management…
11 January 2026
···
Amgen stock slides into weekend as JPMorgan healthcare conference looms

Amgen stock slides into weekend as JPMorgan healthcare conference looms

NEW YORK, Jan 10, 2026, 17:43 EST — Market closed. Shares of Amgen Inc. closed down on Friday, marking a second consecutive day of losses as investors prepared for a new batch of healthcare conference updates. The timing is key as deal discussions pick up again with executives and bankers gathering in San Francisco for the J.P. Morgan Healthcare Conference,…
10 January 2026
·····

Stock Market Today

  • Fujikura Ltd. Stock Gains Reflect Robust 27% Return on Equity and Strong Earnings Growth
    January 24, 2026, 8:16 PM EST. Fujikura Ltd. (TSE:5803) saw its stock rise 1.6% over the past month, supported by a strong return on equity (ROE) of 27%, well above the industry average of 7.6%. ROE measures how efficiently a company generates profits from shareholder investments. Over the trailing twelve months, Fujikura earned ¥0.27 for every ¥1 of equity. The company's net income surged 49% over five years, outpacing the industry growth of 14%. Its solid profit retention rate of 74% suggests efficient reinvestment toward future growth. These financial health indicators align with market performance, indicating Fujikura's fundamentals are driving its stock gains.
Go toTop